Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients’ prognosis

References

• Lala PK, Orucevic A. Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 1998; 17: 91–106
   PubMed Web of Science ®Google Scholar
• Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998; 19: 711–21
   PubMed Web of Science ®Google Scholar
• Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998; 90: 587–96
   PubMed Web of Science ®Google Scholar
• Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995; 92: 4392–6
   PubMed Web of Science ®Google Scholar
• Chiarugi V, Magnelli L, Gallo O. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis. Int J Mol Med 1998; 2: 715–19
   PubMed Web of Science ®Google Scholar
• Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994; 367: 576–9
   PubMed Web of Science ®Google Scholar
• Ambs S, Hussain SP, Harris CC. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. Faseb J 1997; 11: 443–8
   PubMed Web of Science ®Google Scholar
• Feng C, Wang L, Jiao L, Liu B, Zheng S, Xie X. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2002; 2: 8
   PubMed Web of Science ®Google Scholar
• Pukkila MJ, Kellokoski JK, Virtaniemi JA, Kumpulainen EJ, Johansson RT, Halonen PM, et al. Inducible nitric oxide synthase expression in pharyngeal squamous cell carcinoma: relation to p53 expression, clinicopathological data, and survival. Laryngoscope 2002; 112: 1084–8
   PubMed Web of Science ®Google Scholar
• Franchi A, Gallo O, Paglierani M, Sardi I, Magnelli L, Masini E, et al. Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis. Head Neck 2002; 24: 16–23
   PubMedGoogle Scholar
• Kokoska MS, Piccirillo JF, el-Mofty SK, Emami B, Haughey BH, Schoinick SB. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy. Cancer 1996; 78: 1693–700
   PubMed Web of Science ®Google Scholar
• Hirvikoski P, Kumpulainen E, Virtaniemi J, Johansson R, Haapasalo H, Marin S, et al. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol 1997; 15: 3111–20
   PubMed Web of Science ®Google Scholar
• Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, et al. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 1998; 82: 2159–65
   PubMed Web of Science ®Google Scholar
• Sittel C, Eckel HE, Damm M, von Pritzbuer E, Kvasnicka HM. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 2000; 110: 1012–17
   PubMed Web of Science ®Google Scholar
• Beatrice F, Cammarota R, Giordano C, Corrado S, Ragona R, Sartoris A, et al. Angiogenesis: prognostic significance in laryngeal cancer. Anticancer Res 1998; 18: 4737–40
   PubMed Web of Science ®Google Scholar
• Neuchrist C, Quint C, Pammer A, Burian M. Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol (Stockh) 1999; 119: 732–8
   PubMed Web of Science ®Google Scholar
• Burian M, Quint C, Neuchrist C. Angiogenic factors in laryngeal carcinomas: do they have prognostic relevance?. Acta Otolaryngol (Stockh) 1999; 119: 289–92
   PubMedGoogle Scholar
• Kupisz K, Chibowski D, Klatka J, Klonowski S, Stepulak A. Tumor angiogenesis in patients with laryngeal cancer. Eur Arch Otorhinolaryngol 1999; 256: 303–5
   PubMedGoogle Scholar
• Brennan PA, Palacios-Callender M, Zaki GA, Spedding AV, Langdon JD. Type II nitric oxide synthase (NOS2) expression correlates with lymph node status in oral squamous cell carcinoma. J Oral Pathol Med 2001; 30: 129–34
   PubMedGoogle Scholar
• Bandoh N, Hayashi T, Kishibe K, Takahara M, Imada M, Nonaka S, et al. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Cancer 2002; 94: 1968–80
   PubMed Web of Science ®Google Scholar
• Bandoh N, Hayashi T, Takahara M, Kishibe K, Ogino T, Katayama A, et al. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis. Cancer Lett 2004; 208: 215–25
   PubMedGoogle Scholar
• Rieder J, Marth C, Totzke G, Smolny M, Seibel M, Hoffmann G. Different patterns of inducible nitric oxide synthase gene expression in ovarian carcinoma cell lines. Anticancer Res 2000; 20: 3251–8
   PubMedGoogle Scholar
• Kropveld A, Slootweg PJ, van Mansfeld AD, Blankenstein MA, Hordijk GJ. Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis. Cancer 1996; 78: 991–7
   PubMedGoogle Scholar
• Song ZJ, Gong P, Wu YE. Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 2002; 8: 591–5
   PubMed Web of Science ®Google Scholar
• Lagares-Garcia JA, Moore RA, Collier B, Heggere M, Diaz F, Qian F. Nitric oxide synthase as a marker in colorectal carcinoma. Am Surg 2001; 67: 709–13
   PubMedGoogle Scholar